Twin Lakes Capital Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Twin Lakes Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	BUY	$0.14 - $1.07 $1,750 - $13,375	12,500 New	12,500 $2,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $83,160 - $163,485	-94,500 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$2.62 - $3.45 $247,590 - $326,025	94,500 New	94,500 $259,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.